We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£41.00
LAP Lambert Academic Publishing Oral Riboflavin versus Propranolol in the Prophylaxis of Migraine: An Open label Prospective Randomized Controlled trial
Price data last checked 75 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£41 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 16 days • 16 data points (No recent data available)
Price Distribution
Price distribution over 16 days • 1 price levels
Price Analysis
Most common price: £41 (16 days, 100.0%)
Price range: £41 - £41
Price levels: 1 different prices over 16 days
Product Specifications
- Format
- paperback
- ASIN
- 3659247316
- Domain
- Amazon UK
- Release Date
- 24 September 2012
- Listed Since
- 03 April 2013
Barcode
No barcode data available
Similar Products You Might Like
The 2023-2028 Outlook for Anti-Migraine Drugs in Japan
The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America
The 2023-2028 Outlook for Anti-Migraine Drugs in India
The 2023-2028 Outlook for Anti-Migraine Drugs in the United States
The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean
The 2023-2028 Outlook for Anti-Migraine Drugs in China
The 2016-2021 Outlook for Anti-Migraine Drugs in the United States
The 2016-2021 Outlook for Anti-Migraine Drugs in Europe
The 2016-2021 Outlook for Anti-Migraine Drugs in India
The 2016-2021 Outlook for Anti-Migraine Drugs in Asia
The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City
The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China
The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East
The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East
The 2021-2026 World Outlook for Anti-Migraine Drugs
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
OmniScriptum
The 2013-2018 Outlook for Anti-Migraine Drugs in Africa
Management of Migraine Pain: Emerging Opportunities and Challenges
Springer
The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East
The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
Academic Press - Interventional Management of Migraines
Academic Press
Migraine, Words and Fiction
Cambridge Scholars Publishing
The Biochemistry of Migraine
Springer